- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
With Open Enrollment on Horizon, Young People Key to Obamacare's Success
The Obama administration hopes to attract more than 2.5 million young, healthy people to enroll through the health insurance exchanges that open on Oct. 1.
Aside from House Republicans' 40th attempt last week to repeal or revise the Affordable Care Act, commonly known as "Obamacare," and their threat to shut down the government on Oct. 1 if the program is not defunded, the Obama administration's implementation of the health care reform law faces another roadblock -- getting young people to enroll. Open enrollment for health insurance exchanges kicks off Oct. 1 and in order for the program to be a success, young adults need to sign up.
Seven million people is the magic number the Obama administration hopes to have enrolled by the end of March. Of that, they want more than 2.5 million to be made up of young, healthy people to offset the costs of caring for the old and sick.
That goal may not be an easy feat. According to a Kaiser Family Foundation poll, 51 percent of 18-29-year-olds are unaware that the Affordable Care Act is still the law. And with outside parties' campaigns to dissuade this key demographic, convincing them to choose coverage over a fine could be a tough sell.
Read the full story here: http://to.pbs.org/12Yhu4w
Source: PBS
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH
April 15th 2025A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.
Read More
